Comparison of in-Hospital Outcome after Percutaneous Coronary Intervention Between Patients with Anterior Myocardial Infarction and Those With or Without Ramus Intermedius

Document Type: Original Article


Cardiologist, Cardiovascular Research Center, Tabriz University of Medical Sciences, Tabriz, Iran


Introduction: Primary percutaneous coronary intervention (PPCI) is used for the treatment of ST segment elevation myocardial infarction (STEMI). Anterior STEMI is associated with adverse outcomes, and it is possible that the presence of ramus intermedius (RI) would inversely affect the outcome. This research involved the evaluation of the influence of RI presence on clinical outcomes in patients with anterior STEMI and culprit lesion in the left anterior descending artery (LAD).  
Matherials and Methods: This study was conducted on 105 patients with acute anterior STEMI undergoing PPCI in Shahid Madani Hospital, Tabriz, Iran, from April 2016 to March 2018. The recorded data included the patients’ demographic and baseline data, angiographic features, presence of RI, the occurrence of heart failure (HF), cardiogenic shock, and in-hospital and one-year mortality. All data were analyzed, using SPSS software (version 23; SPSS Inc., Chicago, IL). Chi-square test, Fischer’s exact test, independent t-test, or Mann-Whitney U test were employed to compare data between the two groups. A p-value ​less than 0.05 were considered statistically significant.
Results: In this research, RI was present in 53 patients (50.5%). The RI presence was mostly detected in male patines than in their female counterparts (88.7% vs. 69.2%; P=0.01). In addition, those with RI presence had a lower rate of single-vessel disease (60.4% vs. 80.8%; P=0.01) and higher proximal LAD involvement (71.7% vs. 32.7%; P<0.001). After the intervention, ST segment decreased more than 50% and was significantly higher in patients with RI, compared to those without it (52.8% vs. 25.5%; P=0.004). Furthermore, there were no significant differences between the groups regarding cardiac enzymes, ejection fraction, HF, cardiogenic shock, and in-hospital and one-year mortality rates.
Conclusion: The presence of RI was associated with more proximal LAD lesions and less frequent single-vessel disease. However, RI did not seem to influence in-hospital and one-year outcomes.


1. Chehab O, Qannus AS, Eldirani M, Hassan H, Tamim H, Dakik HA. Predictors of in-hospital mortality in patients admitted with acute myocardial infarction in a developing country. Cardiol Res. 2018; 9:293-9.

2. Galbraith EM, McDaniel MC, Jeroudi AM, Kashlan OR, Suo J, Giddens D, et al. Comparison of location of "culprit lesions" in left anterior descending coronary artery among patients with anterior wall ST-segment elevation myocardial infarction having ramus intermedius coronary arteries versus patients not having such arteries. Am J Cardiol. 2010; 106:162-6.

3. Smilowitz NR, Feit F. The history of primary angioplasty and stenting for acute myocardial infarction. Curr Cardiol Rep. 2016; 18:5.

4. Marchesini J, Campo G, Righi R, Benea G, Ferrari R. Coronary artery anomalies presenting with ST-segment elevation myocardial infarction. Clin Pract. 2011; 1:e107.

5. Koşar P, Ergun E, Oztürk C, Koşar U. Anatomic variations and anomalies of the coronary arteries: 64-slice CT angiographic appearance. Diagn Interv Radiol. 2009; 15:275-83.

6. O'Brien JP, Srichai MB, Hecht EM, Kim DC, Jacobs JE. Anatomy of the heart at multidetector CT: what the radiologist needs to know. Radiographics. 2007; 27:1569-82.

7. Kultida CH, Ruedeekorn SW, Keerati HS. Anatomic variants and anomalies of coronary arteries detected by computed tomography angiography in southern Thailand. Med J Malaysia. 2018; 73:131-6.

8. McDaniel MC, Galbraith EM, Jeroudi AM, Kashlan OR, Eshtehardi P, Suo J, et al. Localization of culprit lesions in coronary arteries of patients with ST-segment elevation myocardial infarctions: relation to bifurcations and curvatures. Am Heart J. 2011; 161:508-15.

9. Antoni ML, Yiu KH, Atary JZ, Delgado V, Holman ER, van der Wall EE, et al. Distribution of culprit lesions in patients with ST-segment elevation acute myocardial infarction treated with primary percutaneous coronary intervention. Coron Artery Dis. 2011; 22:533-6.

10. Kelly DJ, Gershlick T, Witzenbichler B, Guagliumi G, Fahy M, Dangas G, et al. Incidence and predictors of heart failure following percutaneous coronary intervention in ST-segment elevation myocardial infarction: the HORIZONS-AMI trial. Am Heart J. 2011; 162:663-70.

11. Cretu DE, Udroiu CA, Stoicescu CI, Tatu-Chitoiu G, Vinereanu D. Predictors of in-hospital mortality of st-segment elevation myocardial infarction patients undergoing interventional treatment. an analysis of data from the RO-STEMI registry. Maedica (Buchar). 2015; 10:295-303.

12. Glancy DL. Late presentation of acute myocardial infarction due to ramus intermedius disease. Proc (BaylUniv Med Cent). 2017; 31:70-1.